Ayman Saad

5.5k total citations
76 papers, 578 citations indexed

About

Ayman Saad is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Ayman Saad has authored 76 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 27 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Ayman Saad's work include Hematopoietic Stem Cell Transplantation (26 papers), Immune Cell Function and Interaction (13 papers) and Acute Myeloid Leukemia Research (12 papers). Ayman Saad is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), Immune Cell Function and Interaction (13 papers) and Acute Myeloid Leukemia Research (12 papers). Ayman Saad collaborates with scholars based in United States, Saudi Arabia and Egypt. Ayman Saad's co-authors include Lawrence S. Lamb, Jame Abraham, Lesley-Ann Miller, Wael Saber, Parameswaran Hari, William R. Drobyski, Jeanne Palmer, Hisham Abdel‐Azim, Haitham Abdelhakim and J. Douglas Rizzo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ayman Saad

67 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Saad United States 11 269 239 152 87 68 76 578
Kyung‐Nam Koh South Korea 14 151 0.6× 297 1.2× 166 1.1× 60 0.7× 40 0.6× 89 660
Aarthi Shenoy United States 13 189 0.7× 327 1.4× 117 0.8× 93 1.1× 109 1.6× 41 649
Meerim Park South Korea 16 119 0.4× 191 0.8× 77 0.5× 90 1.0× 51 0.8× 49 521
Kuang‐Yueh Chiang United States 12 122 0.5× 229 1.0× 139 0.9× 120 1.4× 44 0.6× 31 481
Gergely Kriván Hungary 12 114 0.4× 157 0.7× 158 1.0× 54 0.6× 114 1.7× 58 449
Yoshiko Matsuhashi Japan 12 147 0.5× 336 1.4× 117 0.8× 77 0.9× 49 0.7× 41 521
Michael M. Schündeln Germany 11 160 0.6× 80 0.3× 98 0.6× 95 1.1× 62 0.9× 29 474
Simona Lapusan France 15 271 1.0× 350 1.5× 109 0.7× 146 1.7× 64 0.9× 33 676
Emma Vernon United States 5 103 0.4× 256 1.1× 176 1.2× 63 0.7× 58 0.9× 9 738
Benjamin Tomlinson United States 15 146 0.5× 211 0.9× 59 0.4× 233 2.7× 120 1.8× 63 642

Countries citing papers authored by Ayman Saad

Since Specialization
Citations

This map shows the geographic impact of Ayman Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Saad more than expected).

Fields of papers citing papers by Ayman Saad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Saad. The network helps show where Ayman Saad may publish in the future.

Co-authorship network of co-authors of Ayman Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Saad. A scholar is included among the top collaborators of Ayman Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Saad. Ayman Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeFilipp, Zachariah, Hannah Choe, Yvonne A. Efebera, et al.. (2025). RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT. Blood. 146(17). 2037–2046. 1 indexed citations
2.
Al‐Jefri, Abdullah, Ahmad S. Alotaibi, Mansour Alfayez, et al.. (2024). First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families. Blood. 144(Supplement 1). 5706–5706.
3.
4.
Chaudhri, Naeem, Ayman Saad, Abdullah Alamer, et al.. (2023). The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience. Blood. 142(Supplement 1). 6936–6936. 1 indexed citations
5.
Srour, Samer A., Amandeep Salhotra, Robert Lowsky, et al.. (2023). CT-632 Orca-Q Demonstrates Favorable Graft-Versus-Host Disease (GvHD) and Relapse-Free Survival With Haploidentical Donors Without Post-Transplant Cyclophosphamide. Clinical Lymphoma Myeloma & Leukemia. 23. S537–S537. 1 indexed citations
6.
Faisal, Muhammad Salman, Walter Hanel, Timothy Voorhees, et al.. (2023). Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents. Cancer Medicine. 12(7). 8228–8237. 2 indexed citations
7.
8.
Cook, Michael, Kepher H. Makambi, Yutong Luo, et al.. (2022). Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients. Blood Advances. 7(1). 32–39. 61 indexed citations
9.
Jamy, Omer, et al.. (2022). Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation. Transplantation and Cellular Therapy. 28(4). 213.e1–213.e6. 8 indexed citations
10.
Quittet, Philippe, et al.. (2022). Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania. Annals of Hematology. 101(5). 1015–1022. 1 indexed citations
11.
Sigmund, Audrey M., Nathan Denlinger, Patrick Elder, et al.. (2021). Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution. Blood. 138(Supplement 1). 3851–3851. 2 indexed citations
12.
Wall, Sarah, Ying Huang, Carolyn J. Presley, et al.. (2021). Increasing Number of Geriatric Assessment-Identified Deficits Associated with Non-Receipt of Transplant Among Older Adults. Transplantation and Cellular Therapy. 27(3). S437–S438. 1 indexed citations
13.
Schaefer, Andrew, Ying Huang, Adam S. Kittai, et al.. (2021). Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience. Cancer Management and Research. Volume 13. 8901–8906. 17 indexed citations
14.
Zhao, Qiuhong, Patrick Elder, Jonathan E. Brammer, et al.. (2020). Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Leukemia & lymphoma. 62(4). 944–951. 5 indexed citations
15.
Saad, Ayman, Antonio Di Stasi, Luciano J. Costa, et al.. (2018). Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant. Bone Marrow Transplantation. 53(10). 1345–1348. 3 indexed citations
16.
Marques, Marisa B., et al.. (2018). Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications. Biology of Blood and Marrow Transplantation. 25(2). 233–238. 10 indexed citations
17.
Saad, Ayman & Lawrence S. Lamb. (2017). Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future. Bone Marrow Transplantation. 52(9). 1241–1248. 57 indexed citations
18.
Kanate, Abraham S., Michael Craig, Aaron Cumpston, et al.. (2011). Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 4(4). 149–156. 4 indexed citations
19.
Drobyski, William R., Marcelo C. Pasquini, Jeanne Palmer, et al.. (2011). Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(12). 1862–1868. 88 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung‐Nam Koh Breakdown of academic impact, for papers by Aarthi Shenoy Breakdown of academic impact, for papers by Meerim Park Breakdown of academic impact, for papers by Kuang‐Yueh Chiang Breakdown of academic impact, for papers by Gergely Kriván Breakdown of academic impact, for papers by Yoshiko Matsuhashi Breakdown of academic impact, for papers by Michael M. Schündeln Breakdown of academic impact, for papers by Simona Lapusan Breakdown of academic impact, for papers by Emma Vernon Breakdown of academic impact, for papers by Benjamin Tomlinson
Rankless by CCL
2026